Carlos Trujillo
Directeur Financier/CFO chez PHARMACYTE BIOTECH, INC.
Fortune : 22 048 $ au 30/04/2024
Profil
Carlos A.
Trujillo is currently the Chief Financial Officer at PharmaCyte Biotech, Inc. He previously held the position of Chief Financial Officer at VelaTel Global Communications, Inc. from 2008 to 2014 and at California Cove Communities, Inc. in 2008.
He also worked as the Chief Financial Officer at Viridis Biotech, Inc. Mr. Trujillo obtained his undergraduate degree from California State University-Fullerton in 1982.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARMACYTE BIOTECH, INC.
0,12% | 20/03/2024 | 10 400 ( 0,12% ) | 22 048 $ | 30/04/2024 |
Postes actifs de Carlos Trujillo
| Sociétés | Poste | Début |
|---|---|---|
| PHARMACYTE BIOTECH, INC. | Directeur Financier/CFO | 01/03/2017 |
Anciens postes connus de Carlos Trujillo
| Sociétés | Poste | Fin |
|---|---|---|
| VELATEL GLOBAL COMMUNICATIONS INC | Directeur Financier/CFO | 01/09/2014 |
| California Cove Communities, Inc. | Directeur Financier/CFO | 01/01/2008 |
Viridis Biotech, Inc.
 Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The private company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Directeur Financier/CFO | - |
Formation de Carlos Trujillo
| California State University-Fullerton | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARMACYTE BIOTECH, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
VelaTel Global Communications, Inc.
 VelaTel Global Communications, Inc. Specialty TelecommunicationsCommunications VelaTel Global Communications, Inc. provides capital, engineering, architectural and construction services related to the build-out of wireless broadband telecommunications networks, which it then operates by offering services attractive to residential, enterprise and government subscribers. Its focus is on the deployment of telecommunications networks that utilize Wireless Broadband Access in emerging international markets. The company was founded on September 19, 2005 and is headquartered in Carlsbad, CA. | Communications |
| California Cove Communities, Inc. | |
Viridis Biotech, Inc.
Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The private company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Health Technology |
